首页> 外文期刊>Chinese Medical Journal >Vascular endothelial growth factor expressing mesenchymal stem cells improves cardiac function in chronic myocardial infarction in pigs
【24h】

Vascular endothelial growth factor expressing mesenchymal stem cells improves cardiac function in chronic myocardial infarction in pigs

机译:表达间充质干细胞的血管内皮生长因子改善猪慢性心肌梗死的心脏功能

获取原文
获取原文并翻译 | 示例
           

摘要

Transplantation of mesenchymal stem cells (MSCs) for myocardial reconstruction has shown promise in both animal models and human phase 1 clinical studies. Vascular endothelial growth factor (VEGF) is a strong therapeutic agent for treating ischaemia by inducing angiogenesis. The feasibility of ex vivo MSCs mediated gene transfer is documented. Matsumoto and colleagues have recently reported genetically engineered MSCs carrying VEGF165 delivery for revascularization in a model of acute myocardial infarction (MI). The promising data from our laboratory in both angiogenesis and MSCs transplantation in cunicular heart model of acute MI have prompted us to attempt the combined and simultaneous application of the two strategies.
机译:在动物模型和人类1期临床研究中,用于心肌重建的间充质干细胞(MSC)的移植都显示出了希望。血管内皮生长因子(VEGF)是通过诱导血管生成来治疗局部缺血的强效治疗剂。记载了离体MSC介导的基因转移的可行性。 Matsumoto及其同事最近报道了在急性心肌梗死(MI)模型中携带VEGF165传递基因的MSC,用于血管重建。在急性心肌梗死的心室模型中,来自我们实验室的血管生成和MSCs移植方面的有希望的数据促使我们尝试将两种策略同时应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号